查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1837383

外科网片市场按产品类型、固定方法、来源类型、应用和最终用户划分－2025-2032年全球预测

Surgical Mesh Market by Product Type, Fixation Technique, Source Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，外科网片市场将成长至 60.5 亿美元，复合年增长率为 7.27%。

主要市场统计数据
基准年2024年 34.5亿美元
预计年份：2025年 36.9亿美元
预测年份：2032年 60.5亿美元
复合年增长率 (%) 7.27%

对外科网片生态系统的细緻概述，将材料创新、临床期望和现代医疗保健中的采购压力联繫起来。

外科网片仍然是重组和修復手术的基石，其材料性能、固定可靠性和临床疗效的综合作用决定了患者的康復轨迹。过去十年，临床医生和製造商在聚合物化学、生物整合和手术流程改进等创新推动下，不断适应不断变化的市场环境，同时监管审查和报销压力也影响网片的应用趋势。因此，相关人员必须结合临床证据和供应链实际情况来解读网片，从而优先考虑那些既安全又有价值的投资。

同时，患者对微创手术和降低併发症发生率的期望日益提高，使得器械设计和固定策略的重要性也随之提升。医疗系统越来越需要可靠的真实世界证据和成本效益数据，以证明能够改善患者报告的疗效并缩短住院时间。因此，现代市场观点已超越器械本身的属性，涵盖了其生命週期性能、手术团队的培训需求以及与不断发展的临床路径的契合度。

透过强调材料科学、临床实践和宏观经济力量之间的相互作用，这一做法为后续分析奠定了基础，并为深入检验变革性转变、关税影响、细分细微差别和区域动态奠定了基础，这将指南製造商、医疗保健提供者和投资者的策略决策。

材料科学突破、固定技术创新、监管趋严以及供应链韧性如何重塑外科网片产业的竞争格局

外科网片领域正经历变革时期，这场变革正在重塑产品研发的重点和临床应用模式。可吸收聚合物和混合结构的进步正在重新定义外科医生如何在短期支撑和长期组织整合之间取得平衡，而表面工程和孔隙率的改进则旨在减少感染和粘连。因此，器械的差异化越来越依赖材料的创新，以及在功能性结果和减少併发症可证实的优势。

同时，固定方法正从传统的缝合和钉合方式发展为微创黏合技术，后者优先考虑手术效率和减少患者不适。标准化训练和针对特定手术流程的指导日益受到重视，进一步强化了这一转变，从而促使不同医疗机构获得更一致的治疗效果。此外，日益严格的监管环境也促使製造商加强对严谨的临床证据和上市后监测的投入，这体现在采购决策和与支付方的沟通上。

此外，在地缘政治不确定性和贸易政策不断变化的背景下，供应链韧性和区域製造地正变得日益重要。这些趋势共同加速了医疗器材创新者、契约製造製造商和临床研究机构之间的整合与伙伴关係，以确保在维持创新管道的同时，保持灵活性和合规性。

评估美国关税措施如何改变外科网片价值链中的采购决策、生产在地化和采购实务。

美国加征关税对外科网片相关相关人员产生了多方面的影响，包括采购、生产策略和临床应用。关税带来的成本压力促使采购商和製造商重新评估筹资策略，并加快对近岸外包和国内生产能力的关注，以减轻进口关税的影响并提高库存应对力。随着采购团队寻求稳定总到岸成本，产品规格和包装物流正受到更严格的审查，以寻找提高效率的机会来抵消关税上涨的影响。

面对不断上涨的进口成本，製造商正采取多种应对措施，包括部分生产流程本地化、重新谈判供应商合约以及优化零件采购以维持价格竞争力。这些调整对下游环节产生了切实的影响：供应的连续性成为采购的首要任务，合约条款中纳入了更强有力的应急条款，产品系列在成本结构变化下的利润弹性也得到了评估。医院采购集团和门诊中心越来越多地将关税敏感性纳入供应商评估，更加青睐那些能够展现透明成本模式和供应链冗余的供应商。

临床医生和医院管理者还必须考虑价格调整的间接临床影响，因为供应、前置作业时间和产品选择的变化都会影响手术计划和库存管理。因此，各机构正在协调包括供应链、临床领导和财务在内的跨职能团队，以应对营运方面的影响，同时确保医疗品质和病人安全。

分层細項分析重点在于决定产品策略和市场接受度的材料、固定方法、供应来源、临床用途和最终用户驱动因素。

我们深入的市场区隔揭示了外科网片市场中增量价值与风险的交会点。依产品类型划分，可吸收网片和不可吸收网片的差异反映了不同的研发重点。可吸收网片的创新，包括Polyglactin-Polyglycolic共聚物（PLGA）和聚乙醇酸（PAG）网片等亚型，强调可预测的吸收特性和组织重塑能力；而不可吸收网片，例如可抽出式聚四氟乙烯（PET）网片、聚酯网片和聚丙烯（PP）网片，则强调长期机械支撑和耐用性。这些材料差异最终会影响临床方案、植入选择标准和术后监测策略。

固定技术的细分有助于更清楚地了解其应用动态，因为黏合剂固定、缝合固定和钉子固定各有其优缺点。黏合剂固定又分为生物黏合剂和合成黏合剂，二者在生物相容性和操作特性上有差异。缝合固定则分为连续缝合和间断缝合，二者在手术时间和组织张力控制方面有所不同。钉固定又分为可吸收钉和不可吸收钉，其长期留置异物和潜在的长期併发症等问题会影响外科医生的偏好和患者咨询。

按来源类型进行细分（区分生物来源和合成来源）与监管管道和报销讨论密切相关，影响临床医生对感染风险和整合的认知。基于应用的细分可以识别出具有临床意义的细分领域，例如乳房重建、疝气修补、骨盆器官脱垂、重组手术、压力性尿失禁以及创伤和手术伤口护理。按最终用户进行细分（例如门诊手术中心、诊所和医院）会影响采购行为、合约规模和库存管理，从而指导研发策略和培训投资。

美洲、欧洲、中东和非洲以及亚太地区在临床实践、法律规范和采购行为方面的区域差异，需要量身定制的商业化策略。

区域动态对外科网片产品的开发、生产和分销有显着影响。在美洲，市场活动通常受临床证据的产生、医保报销政策的调整以及对微创解决方案的需求驱动，采购流程则由优先考虑价值和供应安全的综合医疗服务网络和大型医院集团主导。相反，在欧洲、中东和非洲，监管协调工作和多样化的津贴模式正在影响产品的市场推广管道，迫使製造商调整其证据基础和定价策略，以满足各国不同的需求。

亚太市场的特点是基础设施投资快速成长、外科医生对先进技术的熟悉程度不断提高，以及对具有成本竞争力的创新的追求。这些市场也为本地製造伙伴关係和技术转移协议提供了机会，这些合作和技术转移协议既能加速市场准入，又能兼顾区域价格敏感度。不同的区域临床实践模式、监管预期和采购机制，使得制定区域性的商业化计划成为必要，该计划需兼顾全球产品平台与本地相关的循证医学证据和分销策略。

製造商与各地区当地临床领导者之间的合作有助于更有效地进行培训、推广和上市后资料收集，使公司能够根据当地的优先事项和护理服务模式调整产品通讯和支援服务。

如何透过临床证据、生产灵活性、伙伴关係关係生态系统以及以外科医生为中心的价值提案来支撑竞争优势

主要企业之间的竞争日益取决于它们能否将临床证据、生产灵活性和策略伙伴关係关係整合为一个连贯的价值提案。投资于长期疗效研究和完善的上市后监测的市场领导往往在外科界和采购委员会中享有更高的信誉。同时，一些灵活的小型公司和新兴企业正透过专注于新型材料、差异化固定係统或针对特定手术的解决方案来应对持续存在的临床挑战，从而开闢出自己的市场。

策略联盟十分普遍，包括共同开发契约、製造外包合作以及临床研究联盟，旨在加快取得实证医学证据的速度。许多公司也正在探索相关能力，例如手术器械、培训平台和用于追踪结果的数位化解决方案，以提高产品应用率和客户维繫。卓越的品质系统和合规营运有助于市场进入，而透明的供应链实务和在地化筹资策略则能降低贸易中断带来的风险。

对于竞争对手而言，持续的差异化将取决于产品性能与清晰的经济和临床提案主张保持一致，并辅以易于获取的临床医生教育和强大的客户服务模式，从而减少在各种临床环境中采用产品的障碍。

在不断变化的医用网片环境中，製造商和医疗保健提供者可采取切实可行的策略性倡议，以增强其韧性、临床应用和价值实现。

产业领导者应优先考虑一系列切实可行的策略，将竞争考察转化为可持续的竞争优势。首先，投资建立多元化的製造地，将国内生产能力与值得信赖的区域合作伙伴结合，以应对关税风险并缩短前置作业时间。其次，加速收集证据，将医疗器械属性与各类手术中以病人为中心的疗效联繫​​起来，从而加强采购沟通和与支付方的互动。第三，开发模组化产品线，使临床医生能够根据手术偏好和手术中心条件选择可吸收和不可吸收的材料以及固定方式。

领导者还必须加强临床医生教育项目，将固定和网片选择的最佳实践纳入其中，并致力于提供模拟和指导支持，以减少治疗结果的差异。从商业性角度来看，定价和合约策略应反映医疗总成本，而不仅仅是单位成本，并考虑区域报销结构。最后，数位化、服务型产品，例如结果追踪平台和培训课程，能够加强客户参与度，并不断整合真实世界数据，从而指导产品的迭代改进。

综合来看，这些措施将使企业能够在应对日益严格的监管、供应链的不确定性和不断变化的临床期望的同时，专注于永续成长和病人安全。

结合临床医师访谈、采购观点和文献回顾的严谨多源研究框架，能够得出可操作的、基于证据的结论。

本报告的研究结合了对临床医生、采购负责人和行业专家的初步调查，以及对同行评审的临床文献、监管文件和製造商资料的系统性回顾。初步研究包括对多个专科的外科医生进行半结构式访谈，以了解实际临床实践模式；以及与供应链和采购专业人员进行讨论，以了解营运限制和标准。二次研究则揭示了相关背景，包括材料科学的发展、监管指南的更新以及已发表的临床结果研究。

资料综合采用多资讯来源三角验证法来检验主题发现，特别关注临床偏好、购买行为和製造商策略之间的一致性。透过细分映射，将产品属性、固定方法、来源类型、临床用途和最终用户动态整合到一个支援可操作建议的综合框架中。品质保证步骤包括与相关领域专家进行交叉检验以及迭代审查，以确保清晰性和实用性。

我们承认这种调查方法存在固有的局限性：由于监管立场和不断发展的临床证据，具体的解释可能会随时间而改变；区域异质性要求在做出营运决策时，需要当地市场资讯来补充此分析。

对影响外科网片市场产品策略、临床应用和营运韧性的相互关联因素进行综合分析

总之，外科网片领域正处于曲折点，材料创新、不断演进的固定方法、日益严格的监管以及地缘政治压力正在交汇融合，重新定义着战略重点。能够透过高品质证据证明临床价值、调整生产和筹资策略以降低关税和供应风险、并提供以临床医生为中心的解决方案（从而简化选择并改善治疗效果）的企业，才能取得成功。研发、监管、临床和商业团队之间的跨职能合作对于将技术优势转化为可持续的市场差异化至关重要。

展望未来，相关人员应做好准备，迎接对病患报告结局、真实世界证据以及支持临床实践中应用的成本效益型诊疗路径的持续重视。着力打造稳健的业务运作、进行有针对性的临床投资，以及建立能够整合技术和商业性能力的伙伴关係，将使企业能够在日益复杂且竞争激烈的市场环境中，抓住机会，同时满足安全性和价值这两大迫切需求。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 疝气修补手术中生物合成外科网片材料的采用率不断提高
  • 用于复杂骨盆器官脱垂修復的3D列印外科网片创新
  • 聚丙烯网布监管法规日益严格，促使配方改进和风险缓解策略出台。
  • 抗菌涂层网植入可降低腹部手术后的感染率
  • 市场对可吸收网片技术的兴趣日益浓厚，该技术可用于临时组织支撑和减少长期併发症。
  • 开发整合生物感测器的智慧外科网片，用于即时治疗监测和早期併发症检测
  • 推广微创腹腔镜网片植入技术，以加速患者復健并缩短住院时间
  • 製造商与学术机构在先进生物材料研究方面进行策略合作

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的外科网片市场

  • 可吸收网
    • Polyglactin网
    • Polyglycolic网
  • 不可吸收网状物
    • 膨胀聚四氟乙烯网
    • 聚酯网布
    • 聚丙烯网

9. 以固定方式分類的外科网片市场

  • 黏合剂固定
    • 生物黏合剂
    • 合成胶黏剂
  • 缝合固定
    • 连续缝合
    • 间断缝合
  • 底座固定
    • 吸水黏性
    • 不吸水黏性材料

第十章 依来源类型分類的外科网片市场

  • 生物
  • 合成

第十一章 依应用领域分類的外科网片市场

  • 乳房重建
  • 疝气修补术
  • 骨盆器官脱垂
  • 重组手术
  • 应力性尿失禁
  • 创伤/外科性创伤

第十二章 依最终用户分類的外科网片市场

  • 门诊手术中心
  • 诊所
  • 医院

第十三章 各地区外科网片市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 外科网片市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国外科网片市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • 3M Company
    • Angiologica BMSrl
    • Aran Biomedical
    • ASSUT Europe SpA
    • B. Braun Melsungen AG
    • Becton, Dickinson and Company
    • Betatech Medical
    • BG Medical LLC
    • BioCer Entwicklungs-GmbH
    • Boston Scientific Corporation
    • Coloplast Corp.
    • Cousin BIoTech SAS
    • Deep Blue Medical Advances, Inc.
    • Dipromed Srl
    • Dolphin Sutures
    • Integra LifeSciences Corporation
    • Johnson & Johnson Services, Inc
    • KLS Martin Group
    • Lotus Surgicals
    • Medtronic PLC
    • Novus Scientific AB
    • Tela Bio, Inc.
    • THT Bio-Science
    • Vitrex Medical A/S
    • WL Gore & Associates, Inc.
Product Code: MRR-0355054AC4C7

The Surgical Mesh Market is projected to grow by USD 6.05 billion at a CAGR of 7.27% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.45 billion
Estimated Year [2025] USD 3.69 billion
Forecast Year [2032] USD 6.05 billion
CAGR (%) 7.27%

A nuanced overview of the surgical mesh ecosystem that connects material innovation, clinical practice expectations, and procurement pressures in contemporary care

Surgical mesh continues to be a cornerstone in reconstructive and reparative surgery, where material performance, fixation reliability, and clinical outcomes intersect to determine patient recovery trajectories. Over the past decade, clinicians and manufacturers have navigated an evolving landscape shaped by innovations in polymer chemistry, biologic integrations, and technique refinement, all while regulatory scrutiny and reimbursement pressures recalibrate the adoption curve. Consequently, stakeholders must interpret clinical evidence alongside supply chain realities to prioritize investments that deliver both safety and value.

In parallel, patient expectations for minimally invasive procedures and reduced complication rates amplify the importance of device design and fixation strategy. Health systems increasingly demand robust real-world evidence and cost-effectiveness data that demonstrate improved patient-reported outcomes and shorter lengths of stay. Therefore, a modern market perspective extends beyond device attributes to encompass lifecycle performance, training requirements for surgical teams, and alignment with evolving clinical pathways.

This introduction frames the subsequent analysis by emphasizing the interplay between materials science, clinical practice, and macroeconomic forces, setting the stage for a detailed examination of transformative shifts, tariff impacts, segmentation nuances, and regional dynamics that will guide strategic decisions for manufacturers, providers, and investors.

How material science breakthroughs, fixation innovations, regulatory tightening, and supply resilience are redefining competitive priorities across the surgical mesh sector

The surgical mesh landscape is undergoing transformative shifts that are reshaping product development priorities and clinical adoption patterns. Advances in absorbable polymers and hybrid constructs are redefining how surgeons balance short-term support with long-term tissue integration, while improvements in surface engineering and porosity are targeting reductions in infection and adhesion. As a result, device differentiation increasingly hinges on demonstrable benefits in functional outcomes and complication mitigation rather than on material novelty alone.

Concurrently, fixation approaches are evolving from traditional sutures and tacks toward adhesive-based and minimally invasive techniques that prioritize operative efficiency and reduced patient discomfort. This shift is reinforced by a growing emphasis on standardized training and procedure-specific guidance, which together support more consistent outcomes across care settings. In addition, regulatory landscapes have tightened, prompting manufacturers to invest in more rigorous clinical evidence generation and post-market surveillance that, in turn, inform purchasing decisions and payer discussions.

Supply chain resilience and regional manufacturing footprints are also rising in strategic importance amid geopolitical uncertainties and trade policy shifts. Collectively, these dynamics are accelerating consolidation and collaborative partnerships between device innovators, contract manufacturers, and clinical research organizations to ensure agility and compliance while sustaining innovation pipelines.

Assessment of how U.S. tariff policy has reshaped sourcing decisions, manufacturing localization, and procurement practices across the surgical mesh value chain

The application of tariffs in the United States has created multifaceted implications across procurement, manufacturing strategy, and clinical adoption for surgical mesh stakeholders. Tariff-driven cost pressures have prompted purchasers and manufacturers to re-evaluate sourcing strategies, accelerating interest in nearshoring and domestic production capabilities to reduce exposure to import levies and to improve inventory responsiveness. As procurement teams seek to stabilize total landed costs, product specifications and packaging logistics have garnered closer scrutiny to identify efficiency opportunities that offset incremental duties.

Manufacturers facing higher import costs have adopted a range of responses, including localizing certain manufacturing steps, renegotiating supplier contracts, and optimizing component sourcing to preserve competitive pricing. These adjustments have practical downstream effects: supply continuity becomes a procurement priority, contractual terms incorporate more robust contingency provisions, and product portfolios are assessed for margin resilience under altered cost structures. Hospital purchasing groups and ambulatory centers are increasingly integrating tariff sensitivity into vendor evaluations, emphasizing suppliers that demonstrate transparent cost modeling and supply chain redundancy.

Clinicians and hospital administrators must also consider the indirect clinical impact of tariff-induced shifts, since changes in availability, lead times, or product selection can influence procedure planning and inventory management. Consequently, organizations are aligning cross-functional teams-supply chain, clinical leadership, and finance-to navigate the operational implications while maintaining care quality and patient safety.

A layered segmentation analysis clarifying material, fixation, source, clinical application, and end user drivers that determine product strategy and adoption

Insightful segmentation reveals where incremental value and risk converge within the surgical mesh market. Based on product type, the distinction between absorbable mesh and non-absorbable mesh underpins divergent development priorities: absorbable mesh innovations, which include polyglactin mesh and polyglycolic mesh subtypes, emphasize predictable resorption profiles and tissue remodeling, whereas non-absorbable mesh variants such as expanded polytetrafluoroethylene mesh, polyester mesh, and polypropylene mesh focus on long-term mechanical support and durability. These material-based differences cascade into clinical protocols, implant selection criteria, and postoperative surveillance strategies.

Fixation technique segmentation further clarifies adoption dynamics, with adhesive-based fixation, suture-based fixation, and tack-based fixation each presenting distinct trade-offs. Adhesive-based approaches split into biological adhesives and synthetic adhesives, offering varying biocompatibility and handling characteristics, while suture-based fixation differentiates continuous sutures and interrupted sutures in terms of procedural time and tissue tension control. Tack-based fixation, categorized by absorbable tacks and non-absorbable tacks, raises considerations around long-term foreign body presence and potential late complications, which affect surgeon preference and patient counseling.

Source type segmentation, distinguishing biological and synthetic origins, intersects with regulatory pathways and reimbursement discussions, and influences clinician perceptions of infection risk and integration. Application-based segmentation identifies areas of clinical focus-breast reconstruction, hernia repair, pelvic organ prolapse, reconstructive surgery, stress urinary incontinence, and traumatic or surgical wounds-each with unique performance and evidence requirements. End user segmentation across ambulatory surgical centers, clinics, and hospitals shapes purchasing behaviors, contract size, and inventory management, thereby informing go-to-market tactics and training investments.

Regional nuances in clinical practice, regulatory frameworks, and procurement behavior that require tailored commercialization strategies across the Americas, EMEA, and Asia-Pacific

Regional dynamics significantly influence how surgical mesh products are developed, marketed, and distributed. In the Americas, market activity often centers on clinical evidence generation, reimbursement alignment, and demand for minimally invasive solutions, with procurement processes driven by integrated delivery networks and large hospital groups that prioritize value and supply stability. Conversely, in Europe, Middle East & Africa, regulatory harmonization efforts and diverse healthcare funding models shape adoption pathways, prompting manufacturers to tailor evidence dossiers and pricing strategies to meet heterogeneous national requirements.

Asia-Pacific markets are characterized by rapid infrastructure investment, growing surgeon proficiency in advanced techniques, and an appetite for cost-competitive innovations. These markets also present opportunities for local manufacturing partnerships and technology transfer agreements that can accelerate market entry while addressing regional price sensitivity. Each region's distinct combination of clinical practice patterns, regulatory expectations, and procurement mechanisms necessitates regionally calibrated commercialization plans that balance global product platforms with locally relevant evidence and distribution strategies.

Across regions, collaboration between manufacturers and local clinical leaders supports more effective training, adoption, and post-market data collection, enabling companies to adapt product messaging and support services in alignment with regional priorities and care delivery models.

How competitive differentiation is anchored in clinical evidence, manufacturing agility, partnership ecosystems, and surgeon-focused value propositions

Competitive dynamics among key companies are increasingly defined by their ability to integrate clinical evidence, manufacturing agility, and strategic partnerships into coherent value propositions. Market leaders that invest in longitudinal outcomes research and robust post-market surveillance tend to command stronger trust among surgical communities and procurement committees. At the same time, agile smaller players and startups are carving niches by focusing on novel materials, differentiated fixation systems, or procedure-specific solutions that address persistent clinical challenges.

Strategic collaboration is prevalent, with alliances spanning co-development agreements, contract manufacturing partnerships, and clinical research collaborations that accelerate time-to-evidence. Many organizations are also exploring adjacent capabilities such as surgical instrumentation, training platforms, and digital solutions for tracking outcomes to strengthen adoption and customer retention. Operational excellence in quality systems and regulatory compliance bolsters market access, while transparent supply chain practices and localized sourcing strategies mitigate exposure to trade disruptions.

For competitors, sustained differentiation will depend on aligning product performance with clear economic and clinical value propositions, supported by accessible education for clinicians and robust customer service models that reduce barriers to adoption across diverse care settings.

Practical strategic moves for manufacturers and providers to strengthen resilience, clinical adoption, and value realization in a shifting surgical mesh environment

Industry leaders should prioritize a set of actionable strategies to translate market insights into durable competitive advantage. First, invest in diversified manufacturing footprints that combine domestic capabilities with trusted regional partners to manage tariff exposure and to shorten lead times. Second, accelerate evidence generation that links device characteristics to patient-centered outcomes across procedure types, thereby strengthening procurement conversations and payer engagement. Third, develop modular product lines that allow clinicians to select between absorbable and non-absorbable options and to choose fixation methods that align with procedural preferences and site capabilities.

Leaders must also commit to enhanced clinician education programs that embed best practices for fixation and mesh selection, supported by simulation and proctoring that reduce variability in outcomes. From a commercial perspective, pricing and contracting strategies should reflect total cost of care rather than unit price alone, and account for regional reimbursement landscapes. Finally, pursue digital and service-based offerings-such as outcomes tracking platforms and training curricula-that create stickiness with customers and provide ongoing real-world data to inform iterative product improvements.

Collectively, these measures will enable organizations to respond to regulatory intensification, supply chain volatility, and evolving clinical expectations while maintaining a focus on sustainable growth and patient safety.

A rigorous, multi-source research framework combining clinician interviews, procurement perspectives, and literature synthesis to ensure evidence-driven and actionable conclusions

The research underpinning this report combined primary engagement with clinicians, procurement leaders, and industry experts alongside systematic review of peer-reviewed clinical literature, regulatory filings, and manufacturer documentation. Primary research included semi-structured interviews with surgeons across multiple specialties to capture real-world practice patterns, as well as discussions with supply chain and procurement professionals to understand operational constraints and decision criteria. Secondary research provided contextual grounding in material science developments, regulatory guidance updates, and published clinical outcome studies.

Data synthesis relied on triangulation across multiple sources to validate thematic findings, with particular attention to consistency between clinical preferences, purchasing behavior, and manufacturer strategies. Segmentation mapping was applied to align product attributes, fixation techniques, source types, clinical applications, and end user dynamics into an integrated framework that supports actionable recommendations. Quality assurance steps included cross-validation by subject matter experts and iterative review cycles to ensure clarity and practical relevance.

The methodology recognizes inherent limitations: evolving regulatory positions and emerging clinical evidence may alter specific interpretations over time, and regional heterogeneity means that local market intelligence should supplement this analysis when making operational decisions.

Conclusive synthesis of the interconnected forces shaping product strategy, clinical adoption, and operational resilience within the surgical mesh market

In conclusion, the surgical mesh sector is at an inflection point where material innovation, fixation technique evolution, regulatory rigor, and geopolitical pressures converge to redefine strategic priorities. Success will favor organizations that can demonstrate clinical value through high-quality evidence, adapt manufacturing and sourcing strategies to mitigate tariff and supply risks, and deliver clinician-centric solutions that simplify choice and improve outcomes. Cross-functional alignment between R&D, regulatory, clinical affairs, and commercial teams will be essential to translate technical advantages into sustainable market differentiation.

Looking ahead, stakeholders should prepare for continued emphasis on patient-reported outcomes, real-world evidence, and cost-effective care pathways that support adoption across care settings. By focusing on resilient operations, targeted clinical investments, and partnerships that bridge technical and commercial capabilities, organizations can position themselves to meet the dual imperatives of safety and value while capturing opportunities in an increasingly sophisticated and demanding market environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of biosynthetic surgical mesh materials in hernia repair procedures
  • 5.2. Innovations in three-dimensional printed surgical meshes for complex pelvic organ prolapse repair
  • 5.3. Increasing regulatory scrutiny on polypropylene mesh prompting reformulation and risk mitigation strategies
  • 5.4. Emergence of antimicrobial-coated mesh implants to reduce postoperative infection rates in abdominal surgeries
  • 5.5. Growing market interest in absorbable mesh technologies for temporary tissue support and reduced long-term complications
  • 5.6. Development of smart surgical meshes embedded with biosensors for real-time healing monitoring and early complication detection
  • 5.7. Expansion of minimally invasive laparoscopic mesh implantation techniques enhancing patient recovery and reducing hospital stays
  • 5.8. Strategic collaborations between surgical mesh manufacturers and academic institutions for advanced biomaterial research

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Mesh Market, by Product Type

  • 8.1. Absorbable Mesh
    • 8.1.1. Polyglactin Mesh
    • 8.1.2. Polyglycolic Mesh
  • 8.2. Non-Absorbable Mesh
    • 8.2.1. Expanded Polytetrafluoroethylene Mesh
    • 8.2.2. Polyester Mesh
    • 8.2.3. Polypropylene Mesh

9. Surgical Mesh Market, by Fixation Technique

  • 9.1. Adhesive-Based Fixation
    • 9.1.1. Biological Adhesives
    • 9.1.2. Synthetic Adhesives
  • 9.2. Suture-Based Fixation
    • 9.2.1. Continuous Sutures
    • 9.2.2. Interrupted Sutures
  • 9.3. Tack-Based Fixation
    • 9.3.1. Absorbable Tacks
    • 9.3.2. Non-Absorbable Tacks

10. Surgical Mesh Market, by Source Type

  • 10.1. Biological
  • 10.2. Synthetic

11. Surgical Mesh Market, by Application

  • 11.1. Breast Reconstruction
  • 11.2. Hernia Repair
  • 11.3. Pelvic Organ Prolapse
  • 11.4. Reconstructive Surgery
  • 11.5. Stress Urinary Incontinence
  • 11.6. Traumatic/Surgical Wounds

12. Surgical Mesh Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Surgical Mesh Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Surgical Mesh Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Surgical Mesh Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. 3M Company
    • 16.3.2. Angiologica B.M. S.r.l.
    • 16.3.3. Aran Biomedical
    • 16.3.4. ASSUT Europe S.p.A.
    • 16.3.5. B. Braun Melsungen AG
    • 16.3.6. Becton, Dickinson and Company
    • 16.3.7. Betatech Medical
    • 16.3.8. BG Medical LLC
    • 16.3.9. BioCer Entwicklungs-GmbH
    • 16.3.10. Boston Scientific Corporation
    • 16.3.11. Coloplast Corp.
    • 16.3.12. Cousin Biotech SAS
    • 16.3.13. Deep Blue Medical Advances, Inc.
    • 16.3.14. Dipromed Srl
    • 16.3.15. Dolphin Sutures
    • 16.3.16. Integra LifeSciences Corporation
    • 16.3.17. Johnson & Johnson Services, Inc
    • 16.3.18. KLS Martin Group
    • 16.3.19. Lotus Surgicals
    • 16.3.20. Medtronic PLC
    • 16.3.21. Novus Scientific AB
    • 16.3.22. Tela Bio, Inc.
    • 16.3.23. THT Bio-Science
    • 16.3.24. Vitrex Medical A/S
    • 16.3.25. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL MESH MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SURGICAL MESH MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL MESH MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SURGICAL MESH MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL MESH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS SURGICAL MESH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL SURGICAL MESH MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL SURGICAL MESH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. SURGICAL MESH MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. SURGICAL MESH MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SURGICAL MESH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL MESH MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL MESH MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLACTIN MESH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLACTIN MESH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLACTIN MESH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLACTIN MESH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLACTIN MESH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLACTIN MESH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLYCOLIC MESH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLYCOLIC MESH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLYCOLIC MESH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLYCOLIC MESH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLYCOLIC MESH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLYCOLIC MESH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL MESH MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE MESH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL MESH MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE MESH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL MESH MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE MESH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL MESH MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE MESH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL MESH MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE MESH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL MESH MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE MESH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYESTER MESH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYESTER MESH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYESTER MESH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYESTER MESH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYESTER MESH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYESTER MESH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYPROPYLENE MESH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYPROPYLENE MESH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYPROPYLENE MESH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYPROPYLENE MESH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYPROPYLENE MESH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYPROPYLENE MESH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC ADHESIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC ADHESIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC ADHESIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC ADHESIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC ADHESIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC ADHESIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL MESH MARKET SIZE, BY CONTINUOUS SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL MESH MARKET SIZE, BY CONTINUOUS SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL MESH MARKET SIZE, BY CONTINUOUS SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL MESH MARKET SIZE, BY CONTINUOUS SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL MESH MARKET SIZE, BY CONTINUOUS SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL MESH MARKET SIZE, BY CONTINUOUS SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL MESH MARKET SIZE, BY INTERRUPTED SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL MESH MARKET SIZE, BY INTERRUPTED SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL MESH MARKET SIZE, BY INTERRUPTED SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL MESH MARKET SIZE, BY INTERRUPTED SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL MESH MARKET SIZE, BY INTERRUPTED SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL MESH MARKET SIZE, BY INTERRUPTED SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE TACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE TACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE TACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE TACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE TACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE TACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE TACKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE TACKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE TACKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE TACKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE TACKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE TACKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL MESH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL MESH MARKET SIZE, BY BREAST RECONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL MESH MARKET SIZE, BY BREAST RECONSTRUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL MESH MARKET SIZE, BY BREAST RECONSTRUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL MESH MARKET SIZE, BY BREAST RECONSTRUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL MESH MARKET SIZE, BY BREAST RECONSTRUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL MESH MARKET SIZE, BY BREAST RECONSTRUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL MESH MARKET SIZE, BY HERNIA REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL MESH MARKET SIZE, BY HERNIA REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL MESH MARKET SIZE, BY HERNIA REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL MESH MARKET SIZE, BY HERNIA REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL MESH MARKET SIZE, BY HERNIA REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL MESH MARKET SIZE, BY HERNIA REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SURGICAL MESH MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SURGICAL MESH MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SURGICAL MESH MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SURGICAL MESH MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SURGICAL MESH MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SURGICAL MESH MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SURGICAL MESH MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SURGICAL MESH MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SURGICAL MESH MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SURGICAL MESH MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SURGICAL MESH MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SURGICAL MESH MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SURGICAL MESH MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SURGICAL MESH MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SURGICAL MESH MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SURGICAL MESH MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SURGICAL MESH MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SURGICAL MESH MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SURGICAL MESH MARKET SIZE, BY TRAUMATIC/SURGICAL WOUNDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SURGICAL MESH MARKET SIZE, BY TRAUMATIC/SURGICAL WOUNDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SURGICAL MESH MARKET SIZE, BY TRAUMATIC/SURGICAL WOUNDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SURGICAL MESH MARKET SIZE, BY TRAUMATIC/SURGICAL WOUNDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SURGICAL MESH MARKET SIZE, BY TRAUMATIC/SURGICAL WOUNDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SURGICAL MESH MARKET SIZE, BY TRAUMATIC/SURGICAL WOUNDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL MESH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SURGICAL MESH MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SURGICAL MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SURGICAL MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SURGICAL MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SURGICAL MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SURGICAL MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SURGICAL MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SURGICAL MESH MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SURGICAL MESH MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SURGICAL MESH MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SURGICAL MESH MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL MESH MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL MESH MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SURGICAL MESH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL MESH MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL MESH MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SURGICAL MESH MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SURGICAL MESH MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SURGICAL MESH MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SURGICAL MESH MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SURGICAL MESH MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS SURGICAL MESH MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS SURGICAL MESH MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 195. AMERICAS SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 196. AMERICAS SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 197. AMERICAS SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 198. AMERICAS SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 199. AMERICAS SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 200. AMERICAS SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 201. AMERICAS SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 202. AMERICAS SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 203. AMERICAS SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 204. AMERICAS SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS SURGICAL MESH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS SURGICAL MESH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS SURGICAL MESH MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 216. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 218. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 220. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 221. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 222. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 223. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 224. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 225. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 226. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 227. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 238. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 240. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 241. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 242. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 243. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 244. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 245. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 246. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 247. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 248. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 249. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE SURGICAL MESH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE SURGICAL MESH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE SURGICAL MESH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE SURGICAL MESH MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 304. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 305. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 306. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 307. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 308. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 309. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 310. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 311. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 312. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 313. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 314. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 315. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 319. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 320. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 321. AFRICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 322. AFRICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 323. AFRICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. AFRICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. AFRICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 326. AFRICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 327. AFRICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2024 (USD MILLION)
  • TABLE 328. AFRICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2025-2032 (USD MILLION)
  • TABLE 329. AFRICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2024 (USD MILLION)
  • TABLE 330. AFRICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2025-2032 (USD MILLION)
  • TABLE 331. AFRICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 332. AFRICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2025-2032 (USD MILLION)
  • TABLE 333. AFRICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2024 (USD MILLION)
  • TABLE 334. AFRICA SURGICA